Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia

Mohammed Amrallah A.; Ibrahim Hanna M.; Atwa Hanna A.; Elshentenawy Ayman; Elwan Amira

doi:10.2478/fco-2019-0005

Forum of Clinical Oncology (Apr 2020)

Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia

Mohammed Amrallah A.,
Ibrahim Hanna M.,
Atwa Hanna A.,
Elshentenawy Ayman,
Elwan Amira

Affiliations

Mohammed Amrallah A.: Medical Oncology Department, Faculty of Medicine, Zagazig University, Egypt
Ibrahim Hanna M.: Department of Pathology, Faculty of Medicine, Zagazig University
Atwa Hanna A.: Department of Pathology, Faculty of Medicine, Zagazig University
Elshentenawy Ayman: Kasr EL Einy center of clinical oncology and nuclear (NEMROCK), Cairo university, Egypt
Elwan Amira: Clinical oncology Department, Faculty of Medicine, Zagazig University, Egypt

DOI: https://doi.org/10.2478/fco-2019-0005
Journal volume & issue: Vol. 10, no. 2
pp. 15 – 25

Abstract

Read online

Disturbance in cell cycle regulatory genes is a common finding among many types of cancers. The aim of this study is to evaluate the role of cyclin D1 and DJ-1 in benign prostatic hyperplasia (BPH) and prostate cancer (PC).

Published in Forum of Clinical Oncology

ISSN: 1792-362X (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://sciendo.com/journal/FCO

About the journal

Abstract

Keywords